2-[4-(2-methylimidazo[4,5-b]pyridin-3-yl)phenyl]-N-propylacetamide

C18H20N4O — CID 20916146

IUPAC2-[4-(2-methylimidazo[4,5-b]pyridin-3-yl)phenyl]-N-propylacetamide
SMILESCCCNC(=O)Cc1ccc(-n2c(C)nc3cccnc32)cc1
InChIInChI=1S/C18H20N4O/c1-3-10-19-17(23)12-14-6-8-15(9-7-14)22-13(2)21-16-5-4-11-20-18(16)22/h4-9,11H,3,10,12H2,1-2H3,(H,19,23)
InChIKeyWGEDRHCQUKYAOQ-UHFFFAOYSA-N
MW308.38 g/mol
LogP2.80
Rot. Bonds5

About 2-[4-(2-methylimidazo[4,5-b]pyridin-3-yl)phenyl]-N-propylacetamide

2-[4-(2-methylimidazo[4,5-b]pyridin-3-yl)phenyl]-N-propylacetamide (PubChem CID 20916146) has the molecular formula C18H20N4O and a molecular weight of 308.38 g/mol. Its IUPAC name is 2-[4-(2-methylimidazo[4,5-b]pyridin-3-yl)phenyl]-N-propylacetamide.

Molecular Properties

Compound Name2-[4-(2-methylimidazo[4,5-b]pyridin-3-yl)phenyl]-N-propylacetamide
PubChem CID20916146
Molecular FormulaC18H20N4O
Molecular Weight308.38 g/mol
Exact Mass308.16
IUPAC Name2-[4-(2-methylimidazo[4,5-b]pyridin-3-yl)phenyl]-N-propylacetamide
SMILESCCCNC(=O)Cc1ccc(-n2c(C)nc3cccnc32)cc1
InChIInChI=1S/C18H20N4O/c1-3-10-19-17(23)12-14-6-8-15(9-7-14)22-13(2)21-16-5-4-11-20-18(16)22/h4-9,11H,3,10,12H2,1-2H3,(H,19,23)
InChIKeyWGEDRHCQUKYAOQ-UHFFFAOYSA-N
XLogP2.80
TPSA59.81 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds5
Heavy Atoms23
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500308.38
LogP ≤ 52.80
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Analyze 2-[4-(2-methylimidazo[4,5-b]pyridin-3-yl)phenyl]-N-propylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-[4-(2-methylimidazo[4,5-b]pyridin-3-yl)phenyl]-N-[2-(trifluoromethyl)phenyl]acetamide
CID 20916126
2-[4-(2-ethylimidazo[4,5-b]pyridin-3-yl)phenyl]-N-[2-(4-sulfamoylphenyl)ethyl]acetamide
CID 20916194
3-[4-(2-methylimidazo[4,5-b]pyridin-3-yl)phenyl]-N-[(3-methylphenyl)methyl]propanamide
CID 46277233
N-cycloheptyl-3-[4-(2-methylimidazo[4,5-b]pyridin-3-yl)phenyl]propanamide
CID 20916237
3-(4-fluorophenyl)-2-methylimidazo[4,5-b]pyridine
CID 14119097
1-[4-(2,3-dimethylphenyl)piperazin-1-yl]-2-[4-(2-methylimidazo[4,5-b]pyridin-3-yl)phenyl]ethanone
CID 20916164
3-(2-methylimidazo[4,5-b]pyridin-3-yl)-N-[(4-methylphenyl)methyl]benzamide
CID 20916253
2-[4-(2-phenylimidazo[4,5-b]pyridin-3-yl)phenyl]-N-propan-2-ylacetamide
CID 20916212
N-benzyl-3-(2-methylimidazo[4,5-b]pyridin-3-yl)benzamide
CID 20916242
4-(2-methylimidazo[4,5-b]pyridin-3-yl)benzonitrile
CID 15005396
2-[3-(4-methylphenyl)-2-oxoimidazo[4,5-b]pyridin-1-yl]-N-propylacetamide
CID 71841486
2-[2-(4-chlorophenyl)imidazo[4,5-b]pyridin-3-yl]-N-propylacetamide
CID 14390236

Frequently Asked Questions

What is the IUPAC name of 2-[4-(2-methylimidazo[4,5-b]pyridin-3-yl)phenyl]-N-propylacetamide?
The IUPAC name of 2-[4-(2-methylimidazo[4,5-b]pyridin-3-yl)phenyl]-N-propylacetamide (CID 20916146) is 2-[4-(2-methylimidazo[4,5-b]pyridin-3-yl)phenyl]-N-propylacetamide.
What is the SMILES notation for 2-[4-(2-methylimidazo[4,5-b]pyridin-3-yl)phenyl]-N-propylacetamide?
The canonical SMILES for 2-[4-(2-methylimidazo[4,5-b]pyridin-3-yl)phenyl]-N-propylacetamide is CCCNC(=O)Cc1ccc(-n2c(C)nc3cccnc32)cc1.
What is the InChIKey of 2-[4-(2-methylimidazo[4,5-b]pyridin-3-yl)phenyl]-N-propylacetamide?
The InChIKey is WGEDRHCQUKYAOQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H20N4O/c1-3-10-19-17(23)12-14-6-8-15(9-7-14)22-13(2)21-16-5-4-11-20-18(16)22/h4-9,11H,3,10,12H2,1-2H3,(H,19,23).
What are the key properties of 2-[4-(2-methylimidazo[4,5-b]pyridin-3-yl)phenyl]-N-propylacetamide?
2-[4-(2-methylimidazo[4,5-b]pyridin-3-yl)phenyl]-N-propylacetamide has a molecular weight of 308.38 g/mol, XLogP of 2.80, 5 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-(2-methylimidazo[4,5-b]pyridin-3-yl)phenyl]-N-propylacetamide is sourced from PubChem (CID 20916146), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).